Lifestance Health (LFST) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
1.3B
Gross Profit
402.4M
32.17%
Operating Income
-31.6M
-2.53%
Net Income
-57.4M
-4.59%
EPS (Diluted)
-$0.15
Balance Sheet Metrics
Total Assets
2.1B
Total Liabilities
672.0M
Shareholders Equity
1.4B
Debt to Equity
0.46
Cash Flow Metrics
Operating Cash Flow
77.0M
Free Cash Flow
85.7M
Revenue & Profitability Trend
Lifestance Health Income Statement From 2019 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.3B | 1.1B | 859.5M | 667.5M | 212.5M |
| Cost of Goods Sold | 848.6M | 753.6M | 622.5M | 466.0M | 150.1M |
| Gross Profit | 402.4M | 302.1M | 237.0M | 201.5M | 62.4M |
| Operating Expenses | 363.1M | 410.8M | 378.0M | 433.7M | 41.1M |
| Operating Income | -31.6M | -189.1M | -210.2M | -286.4M | 15.2M |
| Pre-tax Income | -57.6M | -206.6M | -232.7M | -333.1M | 7.9M |
| Income Tax | -170.0K | -20.3M | -17.2M | -25.9M | 2.2M |
| Net Income | -57.4M | -186.3M | -215.6M | -307.2M | 5.7M |
| EPS (Diluted) | -$0.15 | -$0.51 | -$0.61 | -$1.05 | -$0.16 |
Income Statement Trend
Lifestance Health Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 312.5M | 225.7M | 233.2M | 266.5M | 76.3M |
| Non-Current Assets | 1.8B | 1.9B | 1.9B | 1.7B | 1.5B |
| Total Assets | 2.1B | 2.1B | 2.2B | 1.9B | 1.6B |
| Liabilities | |||||
| Current Liabilities | 228.9M | 202.9M | 176.0M | 116.8M | 75.9M |
| Non-Current Liabilities | 443.1M | 478.2M | 479.1M | 265.3M | 461.0M |
| Total Liabilities | 672.0M | 681.0M | 655.1M | 382.1M | 536.9M |
| Equity | |||||
| Total Shareholders Equity | 1.4B | 1.4B | 1.5B | 1.5B | 1.0B |
Balance Sheet Composition
Lifestance Health Cash Flow Statement From 2019 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2019 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -57.4M | -186.3M | -215.6M | -307.2M | 5.7M |
| Operating Cash Flow | 77.0M | -50.5M | 39.2M | -30.8M | 10.8M |
| Investing Activities | |||||
| Capital Expenditures | -21.6M | -40.5M | -79.3M | -94.5M | -14.3M |
| Investing Cash Flow | -21.6M | -60.3M | -139.5M | -194.1M | -73.4M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | -9.9M | 47.4M | 47.3M | 313.9M | 48.5M |
| Free Cash Flow | 85.7M | -57.4M | -26.5M | -85.1M | 2.7M |
Cash Flow Trend
Lifestance Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-33.87
Forward P/E
-29.88
Price to Book
1.36
Price to Sales
1.54
PEG Ratio
-29.88
Profitability Ratios
Profit Margin
-2.78%
Operating Margin
0.48%
Return on Equity
-2.47%
Return on Assets
-0.33%
Financial Health
Current Ratio
1.47
Debt to Equity
33.09
Beta
1.22
Per Share Data
EPS (TTM)
-$0.09
Book Value per Share
$3.75
Revenue per Share
$3.37
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| lfst | 2.0B | -33.87 | 1.36 | -2.47% | -2.78% | 33.09 |
| HCA Healthcare | 90.8B | 16.75 | -210.13 | 1,605.77% | 8.07% | -106.02 |
| Tenet Healthcare | 15.7B | 10.85 | 3.76 | 28.82% | 7.09% | 152.20 |
| Ensign Group | 8.7B | 28.71 | 4.51 | 17.64% | 7.00% | 104.09 |
| Chemed | 8.1B | 26.88 | 6.80 | 26.11% | 12.40% | 12.28 |
| Option Care Health | 5.3B | 25.82 | 3.91 | 15.38% | 4.12% | 90.53 |
Financial data is updated regularly. All figures are in the company's reporting currency.